Breadcrumbs Home Investors Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2024-04-08 08:00Application submitted to include an additional terbinafine supplierRead more 2024-02-19 08:00The Nomination Committee's proposal to the Annual General Meeting 2024Read more 2024-02-13 08:00Year-end report 2023Read more 2024-02-07 08:00MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medicationRead more 2023-11-07 08:00Moberg Pharma's Interim report January - September 2023Read more 2023-11-07 07:45Moberg Pharma strengthens the organizationRead more Pagination First page Previous page … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Last page Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2023-10-09 11:00Bulletin from Moberg Pharma's Extraordinary General MeetingRead more 2023-10-06 08:00Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North AmericaRead more 2023-09-29 08:30New number of shares and votes in Moberg Pharma AB (publ)Read more 2023-09-13 08:10Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)Read more 2023-09-13 08:00Clarification regarding directed issue of units to guarantors in connection with the completed rights issueRead more 2023-09-08 11:30Moberg Pharma resolves a directed issue of units to guarantors in connection with the completed rights issueRead more Pagination First page Previous page … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Last page
